Top

Published in:

01-10-2011 | Laboratory Investigation - Human/Animal Tissue

L1 stimulation of human glioma cell motility correlates with FAK activation

Authors: Muhua Yang, Yupei Li, Kalyani Chilukuri, Owen A. Brady, Magdy I. Boulos, John C. Kappes, Deni S. Galileo

Published in: Journal of Neuro-Oncology | Issue 1/2011

Abstract

The neural adhesion/recognition protein L1 (L1CAM; CD171) has been shown or implicated to function in stimulation of cell motility in several cancer types, including high-grade gliomas. Our previous work demonstrated the expression and function of L1 protein in stimulation of cell motility in rat glioma cells. However, the mechanism of this stimulation is still unclear. This study further investigated the function of L1 and L1 proteolysis in human glioblastoma multiforme (GBM) cell migration and invasion, as well as the mechanism of this stimulation. L1 mRNA was found to be present in human T98G GBM cell line but not in U-118 MG grade III human glioma cell line. L1 protein expression, proteolysis, and release were found in T98G cells and human surgical GBM cells by Western blotting. Exosome-like vesicles released by T98G cells were purified and contained full-length L1. In a scratch assay, T98G cells that migrated into the denuded scratch area exhibited upregulation of ADAM10 protease expression coincident with loss of surface L1. GBM surgical specimen cells exhibited a similar loss of cell surface L1 when xenografted into the chick embryo brain. When lentivirally introduced shRNA was used to attenuate L1 expression, such T98G/shL1 cells exhibited significantly decreased cell motility by time lapse microscopy in our quantitative Super Scratch assay. These cells also showed a decrease in FAK activity and exhibited increased focal complexes. L1 binding integrins which activate FAK were found in T98G and U-118 MG cells. Addition of L1 ectodomain-containing media (1) rescued the decreased cell motility of T98G/shL1 cells and (2) increased cell motility of U-118 MG cells but (3) did not further increase T98G cell motility. Injection of L1-attenuated T98G/shL1 cells into embryonic chick brains resulted in the absence of detectable invasion compared to control cells which invaded brain tissue. These studies support a mechanism where glioma cells at the edge of a cell mass upregulate ADAM10 to proteolyze surface L1 and the resultant ectodomain increases human glioma cell migration and invasion by binding to integrin receptors, activating FAK, and increasing turnover of focal complexes.

Claes A, Idema AJ, Wesseling P (2007) Diffuse glioma growth: a guerilla war. Acta Neuropathol 114(5):443–458. doi:10.1007/s00401-007-0293-7 PubMedCrossRef

Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW, Burger PC (1995) Histopathology, classification, and grading of gliomas. Glia 15:211–221PubMedCrossRef

Laerum OD (1997) Local spread of malignant neuroepithelial tumors. Acta Neurochir 139:515–522CrossRef

Viola JJ, Martuza RL (1996) Gene therapies for glioblastomas. Bailliere’s Clin Neurol 5:413–424

Wen P, Fine HA, Black PM, Shrieve DC, Alexander E, Loeffler JS (1995) High-grade astrocytomas. Neurol Clin 13:875–900PubMed

Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492–507PubMedCrossRef

Yang M, Adla S, Temburni MK, Patel VP, Lagow EL, Brady OA, Tian J, Boulos MI, Galileo DS (2009) Stimulation of glioma cell motility by expression, proteolysis, and release of the L1 neural cell recognition molecule. Cancer Cell Int 9:27. doi:10.1186/1475-2867-9-27 PubMedCrossRef

Faissner A, Teplow DB, Kubler D, Keilhauer G, Kinzel V, Schachner M (1985) Biosynthesis and membrane topography of the neural cell adhesion molecule L1. EMBO J 4:3105–3113PubMed

Moos M, Tacke R, Scherner H, Teplow D, Gruth K, Schachner M (1988) Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature 334:701–703PubMedCrossRef

10.

Persohn E, Schachner M (1987) Immunoelectron microscopic localization of the neural cell adhesion molecules L1 and N-CAM during postnatal development of the mouse cerebellum. J Cell Biol 105:569–576PubMedCrossRef

11.

Stallcup WB, Arner L, Levine J (1983) Antiserum against the PC12 cell defines cell surface antigens specific for neurons and Schwann cells. J Neurosci 3:53–69PubMed

12.

Brummendorf T, Kenwrick S, Rathjen FG (1988) Neural cell recognition molecule L1; from cell biology to human hereditary brain malformation. Curr Opin Neurobiol 8:87–97CrossRef

13.

Haspel J, Grumet M (2003) The L1CAM extracellular region: a multidomain protein with modular and cooperative binding modes. Front Biosci 8:s1210–s1225PubMedCrossRef

14.

Hortsch M (1996) The L1 family of neural cell adhesion molecules: old proteins performing new tricks. Neuron 17:587–593PubMedCrossRef

15.

Schachner M (1997) Neural recognition molecules and synaptic plasticity. Curr Opin Cell Biol 9:627–634. doi:10.1186/1475-2867-9-27 PubMedCrossRef

16.

Fransen E, Lemmon V, van Camp G, Vits L, Couchke P, Willems PJ (1995) CRASH syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1. Eur J Hum Genet 3:273–284PubMed

17.

Mechtersheimer S, Gutwein P, Agmon LN, Stoeck A, Oleszewski M, Riedle S, Postina R, Fahrenholz F, Fogel M, Lemmon V, Altevogt P (2001) Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol 155:661–674PubMedCrossRef

18.

Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Gast D, Joumaa S, Zentgraf H, Fogel M, Altevogt DP (2003) ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J 17:292–294PubMed

19.

Gutwein P, Stoeck A, Riedle S, Gast D, Runz S, Condon TP, Marmé A, Phong MC, Linderkamp O, Skorokhod A, Altevogt P (2005) Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin Cancer Res 11(7):2492–2501. doi:10.1158/1078-0432.CCR-04-1688 PubMedCrossRef

20.

Maretzky T, Schulte M, Ludwig A, Rose-John S, Blobel C, Hartmann D, Altevogt P, Saftig P, Reiss K (2005) L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol Cell Biol 25:9040–9053. doi:10.1128/MCB.25.20.9040-9053 PubMedCrossRef

21.

Stoeck A, Keller S, Riedle S, Sanderson MP, Runz S, Le Naour F, Gutwein P, Ludwig A, Rubinstei E, Alevogt P (2006) A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem J 393:609–618. doi:10.1042/BJ20051013 PubMedCrossRef

22.

Itoh K, Fushiki S, Kamiguchi H, Arnold B, Altevogt P, Lemmon V (2005) Disrupted Schwann cell–axon interactions in peripheral nerves of mice with altered L1–integrin interactions. Mol Cell Neurosci 30(4):624–629. doi:10.1016/j.mcn.2005.06.006 PubMed

23.

Liljelund P, Ghosh P, van den Pol AN (1994) Expression of the neural axon adhesion molecule L1 in the developing and adult rat brain. J Biol Chem 269(52):32886–32895PubMed

24.

Yamasaki M, Thompson P, Lemmon V (1997) CRASH syndrome: mutations in L1CAM correlate with severity of the disease. Neuropediatrics 28(3):175–178PubMedCrossRef

25.

Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF (2004) FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6(2):154–161. doi:10.1038/ncb1094 PubMedCrossRef

26.

Mitra SK, Hanson DA, Schlaepfer DD (2005) Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6(1):56–68. doi:10.1038/nrm154 PubMedCrossRef

27.

Ebeling O, Duczmal A, Aigner S, Geiger C, Schollhammer S, Kemshead JT, Moller P, Schwartz-Albiez R, Altevogt P (1996) L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin. Eur J Immunol 26:2508–2516PubMedCrossRef

28.

Montgomery AM, Becker JC, Siu CH, Lemmon VP, Cheresh DA, Pancook JD, Zhao X, Reisfeld RA (1996) Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrins αvβ3. J Cell Biol 132:475–485PubMedCrossRef

29.

Ruppert M, Aigner S, Hubble M, Yagita H, Altevogt P (1995) The L1 adhesion molecule is a cellular ligand for VLA-5. J Cell Biol 131:1881–1891PubMedCrossRef

30.

Kadmon G, Altevogt P (1997) The cell adhesion molecule L1: species- and cell-type-dependent multiple binding mechanisms. Differentiation 61(3):143–150. doi:10.1046/j.1432-0436.1997.6130143.x PubMedCrossRef

31.

Stein GH (1979) T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J Cell Physiol 99(1):43–54PubMedCrossRef

32.

Pontén J, Macintyre EH (1968) Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74(4):465–486PubMedCrossRef

33.

Moscovici H, Moscovici MG, Jimenez H, Lai MM, Hayman MJ, Vogt PK (1977) Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell 11(1):95–103. doi:10.1016/0092-8674(77)90320-8 PubMedCrossRef

34.

Tjio JH, Puck TT (1958) Genetics of somatic mammalian cells. II. Chromosomal constitution of cells in tissue culture. J Exp Med 108:259–271PubMedCrossRef

35.

Chen C, Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7(8):2745–2752PubMed

36.

Li Y, Galileo DS (2010) Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion. Cancer Cell Int 10(1):34 [Epub ahead of print]PubMedCrossRef

37.

Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, Steenbergen RD, Meijer CL, Snijders PJ, Chatis P, Broder TR, Moen PT Jr, Chow LT (2004) Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol 78(20):11172–11186. doi:10.1128/JVI.78.20.11172-11186.2004 PubMedCrossRef

38.

Chen W, Wu X, Levasseur DN, Liu H, Lai L, Kappes JC, Townes TM (2000) Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice. Stem Cells 18(5):352–359. doi:10.1634/stemcells.18-5-352 PubMedCrossRef

39.

Cretu A, Fotos JS, Little BW, Galileo DS (2005) Human and rat glioma growth, invasion, and vascularization in a novel chick embryo brain tumor model. Clin Exp Metastasis 22(3):225–236. doi:10.1007/s10585-005-7889-x PubMedCrossRef

40.

Fotos JS, Patel VP, Karin NJ, Temburni MK, Koh JT, Galileo DS (2006) Automated time-lapse microscopy and high-resolution tracking of cell migration. Cytotechnology 51(1):7–19. doi:10.1007/s10616-006-9006-7 PubMedCrossRef

41.

Raposo G, Nijman HW, Stoorvogel W, Leijendekkerr R, Harding CV, Melief CJM, Geuze HJ (1996) B Lymphocytes secrete antigen-presenting vesicles. J Exp Med 183:1161–1172PubMedCrossRef

42.

Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, Ben-Ze’ev A (2005) L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 168:633–642. doi:10.1083/jcb.200408051 PubMedCrossRef

43.

Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR (2003) Cell migration: integrating signals from front to back. Science 302(5651):1704–1709. doi:10.1126/science.1092053 PubMedCrossRef

44.

Rubenstein M, Shaw M, Mirochnik Y, Slobodskov L, Glick R, Lichtor T, Chou P, Guinan P (1999) In vivo establishment of T98G human glioblastoma. Methods Find Exp Clin Pharmacol 21(6):391. doi:10.1358/mf.1999.21.6.541918 PubMedCrossRef

45.

Smith JS, Jenkins RB (2000) Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 5:D213–D231PubMedCrossRef

46.

Stiles CD, Rowitch DH (2008) Glioma stem cells: a midterm exam. Neuron 58(6):832–846. doi:10.1016/j.neuron,2008.05.031 PubMedCrossRef

47.

Tsuzuki T, Izumoto S, Ohnishi T, Hiraga S, Arita N, Hayakawa T (1998) Neural cell adhesion molecule L1 in gliomas: correlation with TGF-β and p53. J Clin Pathol 51:13–17. doi:10.1136/jcp.51.1.13 PubMedCrossRef

48.

Yamanaka R, Tanaka R, Yoshida S (1993) Effects of irradiation on the expression of the adhesion molecules (NCAM, ICAM-1) by glioma cell lines. Neurol Med Chir (Tokyo) 33(11):749–752CrossRef

49.

Izumoto S, Ohnishi T, Arita N, Hiraga S, Taki T, Hayakawa T (1996) Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion. Cancer Res 56(6):1440–1444PubMed

50.

Ohnishi T, Matsumura H, Izumoto S, Hiraga S, Hayakawa T (1998) A novel model of glioma cell invasion using organotypic brain slice culture. Cancer Res 58(14):2935–2940PubMed

51.

Suzuki T, Izumoto S, Fujimoto Y, Maruno M, Ito Y, Yoshimine T (2005) Clinicopathological study of cellular proliferation and invasion in gliomatosis cerebri: important role of neural cell adhesion molecule L1 in tumour invasion. J Clin Pathol 58(2):166–171. doi:10.1136/jcp.2004.020909 PubMedCrossRef

52.

Shtutman M, Levina E, Ohouo P, Baig M, Roninson IB (2006) Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res 66(23):11370–11380. doi:10.1158/0008-5472.CAN-06-2106 PubMedCrossRef

53.

Meier F, Busch S, Gast D, Göppert A, Altevogt P, Maczey E, Riedle S, Garbe C, Schittek B (2006) The adhesion molecule L1 (CD171) promotes melanoma progression. Int J Cancer 119(3):549–555. doi:10.1002/ijc.21880 PubMedCrossRef

54.

Gavert N, Sheffer M, Raveh S, Spaderna S, Shtutman M, Brabletz T, Barany P, Notterman D, Domany E, Ben-Ze’ev A (2007) Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res 67:16. doi:10.1158/0008-5472.CAN-07-0991 CrossRef

55.

Thies A, Schachner M, Moll I, Berger J, Schulze HJ, Brunner G, Schumacher U (2002) Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur J Cancer 38:1708–1716. doi:10.1016/S0959-8049(02)00105-3 PubMedCrossRef

56.

Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN (2008) Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 68(15):6043–6048. doi:10.1158/0008-5472.CAN-08-1079 PubMedCrossRef

Title: L1 stimulation of human glioma cell motility correlates with FAK activation
Authors: Muhua Yang
Yupei Li
Kalyani Chilukuri
Owen A. Brady
Magdy I. Boulos
John C. Kappes
Deni S. Galileo
Publication date: 01-10-2011
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 1/2011
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-011-0557-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

L1 stimulation of human glioma cell motility correlates with FAK activation

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Serum albumin and survival in glioblastoma multiforme

Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line?

Modern management of rare brain metastases in adults

Differential effects of tumor–platelet interaction in vitro and in vivo in glioblastoma

Usefulness of 13N-NH3 PET in the evaluation of brain lesions that are hypometabolic on 18F-FDG PET

Stereotactic biopsy combined with stereotactic 125iodine brachytherapy for diagnosis and treatment of locally recurrent single brain metastases